No Oral Modification Clause Example from Business Contracts

Employment Agreement, dated February 22, 2022, between the Company and Mr. Bartolo (Filed With SEC on February 22, 2022)

Employment Agreement, dated February 24, 2022, between the Company and R. Brandon Asbill (Filed With SEC on February 25, 2022)

Separation Agreement and Release, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Roger Pomerantz (Filed With SEC on January 15, 2019)

Separation Agreement and Release by and between the Company and Dr. Michele Trucksis, effective November 16, 2018 (Filed With SEC on November 21, 2018)

Separation Agreement and Release, dated as of April 2, 2019, by and between ContraFect Corporation and Steven C. Gilman (Filed With SEC on April 2, 2019)

Transition Agreement and Release, dated as of August 14, 2022, by and between Cara Cassino, M.D. and ContraFect Corporation (Filed With SEC on August 16, 2022)

Separation Agreement, dated October 23 2019, by and between QEP Resources, Inc. and Richard J. Doleshek (Filed With SEC on October 23, 2019)

Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Stephen Smolinski (Filed With SEC on June 25, 2020)

Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Elona Kogan (Filed With SEC on June 25, 2020)

Separation Agreement and Release by and between the Company and Dr. David Mauney, effective May 26, 2020 (Filed With SEC on May 29, 2020)

Separation Agreement and Release between Kenneth Reali and Bioventus Inc., dated April 4, 2023 (Filed With SEC on April 5, 2023)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on July 23, 2013)